Eli Lilly (LLY) has been reported to have approached the French government regarding a potential acquisition of Abivax (ABVX), but both parties have denied these claims. Marc de Garidel, CEO of Abivax, stated that no such discussions occurred, emphasizing that any conversation would be illegal without public disclosure. Despite these denials, Abivax's shares have surged over 1,700% in the past year, fueled by speculation of a buyout and positive trial results for obefazimod, a treatment for ulcerative colitis.
https://www.gurufocus.com/news/6758366/eli-lilly-lly-denies-acquisition-talks-with-abivax-abvx
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.